Abstract
Objective
To provide updated evidence, we conducted a systematic review and meta-analysis to compare citrate lock with heparin in the prevention of hemodialysis catheter-related complications.
Methods
A systematic review and meta-analysis of randomized controlled trials were obtained by searching PubMed, EMBASE, Ovid, Cochrane library, and the Web of Science databases. Primary outcomes were catheter-related bloodstream infections (CRBI), exit-site infections, bleeding events, catheter removal for poor flow, and thrombolytic treatment. Secondary outcomes were thrombocytopenia, access-related admission, and all-cause mortality.
Results
The meta-analysis showed that the citrate lock containing antimicrobials can reduce the risk of CRBI when compared with heparin lock (RR: 0.34, 95% CI 0.24–0.49; I2 = 0%; P < 0.00001), and a tunneled cuffed catheter (TCC) was more beneficial for the prevention of CRBI (RR: 0.42, 95% CI 0.25–0.69; I2 = 40%; P = 0.0007) when compared with non-tunneled cuffed catheters (NTCC). The microbiological correlation analysis suggests that the occurrence of CRBI is closely related to S. aureus in catheters locked by citrate (P = 0.015) rather than by heparin (P = 0.868). In the analysis of exit-site infection, citrate lock with NTCC was more effective in preventing exit-site infection than heparin (RR: 0.48, 95% CI 0.31–0.75; I2 = 0%; P = 0.001). In addition, the risk of bleeding episodes was reduced in hemodialysis patients using citrate lock with TCC (RR: 0.53, 95% CI 0.32–0.86; I2 = 0%; P = 0.01) and patients with citrate alone (RR: 0.51, 95% CI 0.30–0.85; I2 = 12%; P = 0.010). The risk of catheter removal for poor flow (P = 0.91), thrombolytic treatment (P = 0.76), thrombocytopenia (P = 0.37), access-related admission (P = 0.10), and all-cause mortality (P = 0.62) was not significantly different.
Conclusions
Antimicrobial-containing citrate lock solutions could reduce the risk of CRBI in hemodialysis patients. The occurrence of CRBI is closely related to S. aureus in catheters locked by citrate rather than by heparin. Citrate lock was effective in reducing exit-site infection in NTCC and bleeding events in TCC.
Similar content being viewed by others
References
Zhao Y, Li Z, Zhang L et al (2014) Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials. Am J Kidney Dis 63(3):479–490
Liu J, Wang C, Zhao H et al (2015) Anticoagulant therapies versus heparin for the prevention of hemodialysis catheter-related complications: systematic review and meta-analysis of prospective randomized controlled trials. Int J Clin Exp Med 8(8):11985
Barcellos FC, Nunes BP, Valle LJ et al (2017) Comparative effectiveness of 30% trisodium citrate and heparin lock solution in preventing infection and dysfunction of hemodialysis catheters: a randomized controlled trial (CITRIM trial). Infection 45(2):139–145
Luiz MVSJ, Scavone C, Tzanno C (2017) The CLOCK trial, a double-blinded randomized controlled trial: trisodium citrate 30% and minocycline 3 mg/mL plus EDTA 30 mg/mL are effective and safe for catheter patency maintenance among CKD 5D patients on hemodialysis. Hemodial Int 21(2):294–304
Abdel ABEA, ElSaid TW, El HWS et al (2018) A randomized controlled clinical trial of 4% sodium citrate versus heparin as locking solution for temporary dialysis catheters among hemodialysis patients. Clin Nephrol 90(5):341–349
Zhao T, Liu H, Han J (2018) Ethanol lock is effective on reducing the incidence of tunneled catheter-related bloodstream infections in hemodialysis patients: a systematic review and meta-analysis. Int Urol Nephrol. 2018:1–10
Higgins JPT, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ. 327(7414):557
Betjes MGH, van Agteren M (2004) Prevention of dialysis catheter-related sepsis with a citrate–taurolidine-containing lock solution. Nephrol Dial Transplant 19(6):1546–1551
Buturović J, Ponikvar R, Kandus A et al (1998) Filling hemodialysis catheters in the interdialytic period: heparin versus citrate versus polygeline: a prospective randomized study. Artif Organs 22(11):945–947
Dogra GK, Herson H, Hutchison B et al (2002) Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 13(8):2133–2139
Filiopoulos V, Hadjiyannakos D, Koutis I et al (2011) Approaches to prolong the use of uncuffed hemodialysis catheters: results of a randomized trial. Am J Nephrol 33(3):260–268
MacRae JM, Dojcinovic I, Djurdjev O et al (2008) Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS). Clin J Am Soc Nephrol 3(2):369–374
Maki DG, Ash SR, Winger RK et al (2011) A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial. Crit Care Med 39(4):613–620
Moran J, Sun S, Khababa I et al (2012) A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients. Am J Kidney Dis 59(1):102–107
Nori US, Manoharan A, Yee J et al (2006) Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. Am J Kidney Dis 48(4):596–605
Pervez A, Ahmed M, Ram S et al (2002) Antibiotic lock technique for prevention of cuffed tunnel catheter associated bacteremia. J Vasc Access 3(3):108–113
Power A, Duncan N, Singh SK et al (2009) Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial. Am J Kidney Dis 53(6):1034–1041
Solomon LR, Cheesbrough JS, Ebah L et al (2010) A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. Am J Kidney Dis 55(6):1060–1068
Weijmer MC, van den Dorpel MA, Van de Ven PJG et al (2005) Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 16(9):2769–2777
Hendrickx L, Kuypers D, Evenepoel P et al (2001) A comparative prospective study on the use of low concentrate citrate lock versus heparin lock in permanent dialysis catheters. Int J Artif Organs 24(4):208–211
Vercaigne LM, Allan DR, Armstrong SW et al (2016) An ethanol/sodium citrate locking solution compared to heparin to prevent hemodialysis catheter-related infections: a randomized pilot study. J Vasc Access 17(1):55–62
Taylor C, Cahill J, Gerrish M et al (2008) A new haemodialysis catheter-locking agent reduces infections in haemodialysis patients. J Renal Care 34(3):116–120
Niyyar VD (2012) Catheter dysfunction: the role of lock solutions. Seminars in dialysis, vol 25. Blackwell Publishing Ltd, Oxford, pp 693–699
Acknowledgements
This work was supported by National natural science foundation of China (81700588); Sichuan university youth start-up fund project (20826041A4210).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have declared no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Mai, H., Zhao, Y., Salerno, S. et al. Citrate versus heparin lock for prevention of hemodialysis catheter-related complications: updated systematic review and meta-analysis of randomized controlled trials. Int Urol Nephrol 51, 1019–1033 (2019). https://doi.org/10.1007/s11255-019-02150-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-019-02150-0